drugset / Trial / NCT01937767
Remimazolam Phase II Cardiac Anesthesia Study
RandomizedParallel-groupSingle-blindTreatment
Summary
This phase II study in patients undergoing elective cardiac surgery will evaluate the efficacy, safety, and pharmacokinetics of remimazolam, compared with propofol and sevoflurane, during the induction and maintenance of general anesthesia.
Timeline
- Start
- 2013-08
- Primary completion
- 2014-02
- Completion
- 2014-02-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Propofol | Small molecule | — | — |
| Subject | Remimazolam | Small molecule | 2 mg/kg | — |
| Comparator | Sevoflurane | Other / unclassified | — | — |
| Background | Fentanyl | Other / unclassified | — | — |
| Background | Remifentanil | Small molecule | — | — |
| Background | Rocuronium | Other / unclassified | — | — |
Indications
No indication recorded.